Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Advances in Therapy|May 27, 2024
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)Raphael Schiffmann, Eugen Mengel, Mary Wallace, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 13, 2011
Towards nationwide control of schistosomiasis in Yemen: a pilot project to expand treatment to the whole communityAbdullah Oshish, Abdulhakim AlKohlani, Alaa Hamed, et al.
Current Neuropharmacology|March 15, 2026
Aloe Polysaccharides against 3-Nitropropionic acid-induced Huntington's disease-like symptoms: Role of BDNF/NF-κB/Nrf2 signaling pathwaysMisbahuddin Rafeeq, Muhammad Afzal, Alaa Hamed Habib, et al.
Bioinformation|March 22, 2023
Effect of rifampicin combination-regimens against multi-drug resistant strains in North IndiaMisbahuddin M Rafeeq, Alaa Hamed Habib, Ahmad Alzamami, et al.
Biogerontology|June 30, 2025
Translational potential of GADD45α: biomarker and therapeutic target in age-associated neurodegeneration and longevityImran Kazmi, Fahad A Al-Abbasi, Mustafa Zeyadi, et al.
Molecular Genetics and Metabolism|June 13, 2024
Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidosesJulie Kissell, Camille Rochmann, Pascal Minini, et al.
Frontiers in Neuroscience|June 13, 2022
Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer's DiseaseBin Xue, Shah Mohammad Abbas Waseem, Zhixin Zhu, et al.
Journal of Biomolecular Structure & Dynamics|November 1, 2022
PheroxyPyrabenz and Carbopyrropyridin against major proteins of SARS CoV-2: a comprehensive <i>in-silico</i> molecular docking and dynamics simulation studiesMisbahuddin M Rafeeq, Alaa F Nahhas, Najat Binothman, et al.
Orphanet Journal of Rare Diseases|January 12, 2024
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe diseaseMatthias Boentert, Kenneth I Berger, Jordi Díaz-Manera, et al.
Clinical Kidney Journal|April 12, 2021
Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysisAlberto Ortiz, Steve Kanters, Alaa Hamed, et al.
Pageof 8